Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis
Open Access
- 15 September 2008
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 181 (6), 3750-3754
- https://doi.org/10.4049/jimmunol.181.6.3750
Abstract
It has recently been proposed that experimental autoimmune encephalomyelitis, once considered the classical Th1 disease, is predominantly Th17 driven. In this study we show that myelin-reactive Th1 preparations devoid of contaminating IL-17+ cells are highly pathogenic. In contrast, Th17 preparations lacking IFN-γ+ cells do not cause disease. Our key observation is that only Th1 cells can access the noninflamed CNS. Once Th1 cells establish the experimental autoimmune encephalomyelitis lesion, Th17 cells appear in the CNS. These data shed important new light on the ability of Th1 vs Th17 cells to access inflamed vs normal tissue. Because the IL-17-triggered release of chemokines by stromal cells could attract many other immune cells, allowing Th17 cells to access the tissues only under conditions of inflammation may be a key process limiting (auto)immune pathology. This has major implications for the design of therapeutic interventions, many of which are now aiming at Th17 rather than Th1 cells.Keywords
This publication has 16 references indexed in Scilit:
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryThe Journal of Experimental Medicine, 2008
- TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathologyNature Immunology, 2007
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- The Inflamed Central Nervous System Drives the Activation and Rapid Proliferation of Foxp3+ Regulatory T CellsPublished by The American Association of Immunologists ,2007
- An interferon-γ-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitisJournal of Neuroimmunology, 2007
- IL-25 regulates Th17 function in autoimmune inflammationThe Journal of Experimental Medicine, 2007
- CD5-CK2 Binding/Activation-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Protection Is Associated with Diminished Populations of IL-17-Expressing T Cells in the Central Nervous SystemPublished by The American Association of Immunologists ,2006
- The IL-23/Th17 axis: therapeutic targets for autoimmune inflammationCurrent Opinion in Immunology, 2006
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003